Compare CRVO & FUSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRVO | FUSB |
|---|---|---|
| Founded | 2001 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.5M | 80.6M |
| IPO Year | N/A | N/A |
| Metric | CRVO | FUSB |
|---|---|---|
| Price | $7.33 | $13.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $21.50 | N/A |
| AVG Volume (30 Days) | ★ 57.6K | 6.4K |
| Earning Date | 11-10-2025 | 01-23-2026 |
| Dividend Yield | N/A | ★ 2.01% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.93 |
| Revenue | $6,159,786.00 | ★ $36,068,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.99 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.92 | $10.30 |
| 52 Week High | $16.94 | $14.79 |
| Indicator | CRVO | FUSB |
|---|---|---|
| Relative Strength Index (RSI) | 37.66 | 54.46 |
| Support Level | $6.90 | $13.75 |
| Resistance Level | $8.22 | $14.23 |
| Average True Range (ATR) | 0.51 | 0.18 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 14.10 | 55.17 |
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.